Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas

被引:235
作者
Jhiang, SM
Sagartz, JE
Tong, Q
ParkerThornburg, J
Capen, CC
Cho, JY
Xing, SH
Ledent, C
机构
[1] OHIO STATE UNIV, CTR BIOTECHNOL, COLUMBUS, OH 43210 USA
[2] UNIV BRUSSELS, FAC MED, INST RECH INTERDISCIPLINAIRE, BRUSSELS, BELGIUM
关键词
D O I
10.1210/en.137.1.375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ret/PTC oncogene, a rearranged form of the ret proto-oncogene, has been found to be restricted to human papillary thyroid carcinomas. This report shows that transgenic mice with thyroid-targeted expression of the ret/PTC1 oncogene developed thyroid carcinomas with considerable similarities to human papillary thyroid carcinomas, particularly in the nuclear cytologic features and the presence of local invasion. Our findings indicate that ret/PTC1 is not only a biomarker associated with papillary thyroid carcinomas, but is also the only proven specific genetic event leading to the development of papillary thyroid carcinoma.
引用
收藏
页码:375 / 378
页数:4
相关论文
共 15 条
[1]   PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS [J].
GRIECO, M ;
SANTORO, M ;
BERLINGIERI, MT ;
MELILLO, RM ;
DONGHI, R ;
BONGARZONE, I ;
PIEROTTI, MA ;
DELLAPORTA, G ;
FUSCO, A ;
VECCHIO, G .
CELL, 1990, 60 (04) :557-563
[2]  
JHIANG SM, 1992, ONCOGENE, V7, P1331
[3]   DEVELOPMENT OF A SINGLE-STEP DUPLEX RT-PCR DETECTING DIFFERENT FORMS OF RET ACTIVATION, AND IDENTIFICATION OF THE 3RD FORM OF IN-VIVO RET ACTIVATION IN HUMAN PAPILLARY THYROID-CARCINOMA [J].
JHIANG, SM ;
SMANIK, PA ;
MAZZAFERRI, EL .
CANCER LETTERS, 1994, 78 (1-3) :69-76
[4]  
JHIANG SM, 1994, J LAB CLIN MED, V123, P331
[5]   THYROID ADENOCARCINOMAS SECONDARY TO TISSUE-SPECIFIC EXPRESSION OF SIMIAN VIRUS-40 LARGE T-ANTIGEN IN TRANSGENIC MICE [J].
LEDENT, C ;
DUMONT, J ;
VASSART, G ;
PARMENTIER, M .
ENDOCRINOLOGY, 1991, 129 (03) :1391-1401
[6]   MODELS OF THYROID GOITER AND TUMORS IN TRANSGENIC MICE [J].
LEDENT, C ;
PARMENTIER, M ;
VASSART, G ;
DUMONT, JE .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 100 (1-2) :167-169
[7]   GENETIC-BASIS OF ENDOCRINE DISEASE - MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 [J].
MULLIGAN, LM ;
PONDER, BAJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) :1989-1995
[8]  
NAKAMURA T, 1994, J PATHOL, V172, P225
[9]   POINT MUTATIONS AFFECTING THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN HIRSCHPRUNGS DISEASE [J].
ROMEO, G ;
RONCHETTO, P ;
LUO, Y ;
BARONE, V ;
SERI, M ;
CECCHERINI, I ;
PASINI, B ;
BOCCIARDI, R ;
LERONE, M ;
KAARIAINEN, H ;
MARTUCCIELLO, G .
NATURE, 1994, 367 (6461) :377-378
[10]   RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE [J].
SANTORO, M ;
CARLOMAGNO, F ;
HAY, ID ;
HERRMANN, MA ;
GRIECO, M ;
MELILLO, R ;
PIEROTTI, MA ;
BONGARZONE, I ;
DELLAPORTA, G ;
BERGER, N ;
PEIX, JL ;
PAULIN, C ;
FABIEN, N ;
VECCHIO, G ;
JENKINS, RB ;
FUSCO, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1517-1522